Mural Oncology (MURA)

3.35

-0.08 (-2.33%)

At close: Mar 04, 2025, 11:06 AM

Mural Oncology Cash Flow Statement

Table Mode

Year	FY23	FY22	FY21
Net Income	-207.45M	-189.81M	-175.43M
Depreciation & Amortization	2.57M	1.54M	1.47M
Stock-Based Compensation	24.11M	11.93M	11.5M
Other Working Capital	-13.48M	7.75M	5.79M
Other Non-Cash Items	n/a	15.01M	14.45M
Deferred Income Tax	n/a	-15.01M	-14.45M
Change in Working Capital	-13.48M	7.75M	5.79M
Operating Cash Flow	-194.25M	-168.59M	-156.67M
Capital Expenditures	-3.45M	-5.51M	-4.38M
Acquisitions	n/a	n/a	n/a
Purchase of Investments	n/a	n/a	n/a
Sales Maturities Of Investments	n/a	n/a	n/a
Other Investing Acitivies	n/a	n/a	n/a
Investing Cash Flow	-3.45M	-5.51M	-4.38M
Debt Repayment	n/a	n/a	n/a
Common Stock Repurchased	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a
Other Financial Acitivies	468.81M	174.1M	161.05M
Financial Cash Flow	468.81M	174.1M	161.05M
Net Cash Flow	271.11M	n/a	n/a
Free Cash Flow	-197.7M	-174.1M	-161.05M